Sanford C. Bernstein Boosts agilon health (NYSE:AGL) Price Target to $3.15

agilon health (NYSE:AGL) had its price target upped by equities researchers at Sanford C. Bernstein from $2.50 to $3.15 in a research report issued on Wednesday,Benzinga reports. The firm presently has a “market perform” rating on the stock. Sanford C. Bernstein’s price objective suggests a potential upside of 13.72% from the stock’s previous close.

Several other research analysts have also recently commented on AGL. Macquarie assumed coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target for the company. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the company from $1.75 to $2.25 in a report on Friday, January 10th. TD Cowen lowered their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Barclays cut their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Finally, William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $4.03.

agilon health Stock Up 0.7 %

Shares of NYSE AGL traded up $0.02 during midday trading on Wednesday, reaching $2.77. The company’s stock had a trading volume of 1,755,143 shares, compared to its average volume of 4,194,103. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a 50 day simple moving average of $2.07 and a 200-day simple moving average of $3.68. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -2.95 and a beta of 0.53. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. Equities research analysts predict that agilon health will post -0.52 earnings per share for the current year.

Insider Activity

In other news, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Diana Mckenzie bought 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The stock was acquired at an average cost of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 90,000 shares of company stock valued at $198,100. 3.20% of the stock is owned by insiders.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Oak Thistle LLC acquired a new position in shares of agilon health during the 4th quarter worth approximately $25,000. Pines Wealth Management LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $51,000. JPMorgan Chase & Co. grew its position in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after buying an additional 1,083,492 shares in the last quarter. Virtu Financial LLC bought a new position in agilon health during the 3rd quarter worth $120,000. Finally, Geode Capital Management LLC increased its stake in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.